HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 217 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $201,294 | -45.0% | 6,672 | -38.7% | 0.03% | -40.4% |
| Q1 2024 | $365,787 | +67.1% | 10,893 | +60.7% | 0.05% | +9.3% |
| Q4 2023 | $218,897 | +335.7% | 6,777 | +342.1% | 0.04% | +186.7% |
| Q3 2023 | $50,236 | +81.9% | 1,533 | +95.3% | 0.02% | +66.7% |
| Q2 2023 | $27,624 | +4.8% | 785 | -2.7% | 0.01% | 0.0% |
| Q1 2023 | $26,349 | -20.7% | 807 | +33.8% | 0.01% | -30.8% |
| Q4 2022 | $33,225 | +32.9% | 603 | +8.8% | 0.01% | +18.2% |
| Q3 2022 | $25,000 | – | 554 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
| Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
| venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
| Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
| HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
| Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
| ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
| Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |